CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | PAKOLA STEVE Chief Medical Officer | Grant or award · Stock Options (Right to buy) | +44,155 | 44,155 | ||
| 2023-01-03 | Mills Kenneth T. President and CEO | Shares withheld for taxes | −9,308 | $22.68 | $211K | 300,536 |
| 2023-01-03 | Mills Kenneth T. President and CEO | Grant or award | +54,753 | 355,289 | ||
| 2023-01-03 | Mills Kenneth T. President and CEO | Grant or award · Stock Options (Right to buy) | +264,932 | 264,932 | ||
| 2023-01-03 | Danos Olivier Chief Scientific Officer | Shares withheld for taxes | −2,058 | $22.68 | $47K | 27,020 |
| 2023-01-03 | Danos Olivier Chief Scientific Officer | Grant or award | +65,930 | 92,950 | ||
| 2023-01-03 | Danos Olivier Chief Scientific Officer | Grant or award · Stock Options (Right to buy) | +52,986 | 52,986 | ||
| 2023-01-03 | Christmas Patrick J. Chief Legal Officer | Shares withheld for taxes | −1,843 | $22.68 | $42K | 21,097 |
| 2023-01-03 | Christmas Patrick J. Chief Legal Officer | Grant or award | +67,940 | 89,037 | ||
| 2023-01-03 | Christmas Patrick J. Chief Legal Officer | Grant or award · Stock Options (Right to buy) | +56,519 | 56,519 | ||
| 2022-08-30 | Vasista Vittal Chief Financial Officer | Sale | −2,400 | $30.24 | $73K | 135,160 |
| 2022-08-05 | Vasista Vittal Chief Financial Officer | Sale | −17,280 | $35.19 | $608K | 137,560 |
| 2022-08-04 | Vasista Vittal Chief Financial Officer | Sale | −400 | $35.00 | $14K | 154,840 |
| 2022-08-01 | Vasista Vittal Chief Financial Officer | Sale | −2,400 | $31.26 | $75K | 155,240 |
| 2022-07-14 | Vasista Vittal Chief Financial Officer | Sale | −468 | $30.00 | $14K | 157,640 |
| 2022-07-13 | Vasista Vittal Chief Financial Officer | Sale | −4,332 | $30.01 | $130K | 158,108 |
| 2022-06-30 | Danos Olivier Chief Scientific Officer | Grant or award | +728 | $21.00 | $15K | 93,678 |
| 2022-06-03 | Zachary Jennifer Director | Grant or award | +6,020 | 6,020 | ||
| 2022-06-03 | Zachary Jennifer Director | Grant or award · Stock Option (Right to Buy) | +29,739 | 29,739 | ||
| 2022-06-03 | Tasse Daniel Director | Grant or award | +3,010 | 3,010 |
Page 13 of 25 · 494 trades